X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (112) 112
index medicus (83) 83
female (79) 79
male (78) 78
adult (75) 75
oncology (75) 75
middle aged (74) 74
cancer (72) 72
aged (69) 69
life sciences (55) 55
hematology (51) 51
treatment outcome (40) 40
lymphomas (38) 38
chemotherapy (36) 36
[ sdv.can ] life sciences [q-bio]/cancer (34) 34
aged, 80 and over (33) 33
antineoplastic combined chemotherapy protocols - therapeutic use (33) 33
prognosis (30) 30
[sdv.can]life sciences [q-bio]/cancer (27) 27
lymphoma (26) 26
therapy (26) 26
antineoplastic agents - therapeutic use (21) 21
mantle cell lymphoma (20) 20
patients (20) 20
care and treatment (19) 19
survival (18) 18
young adult (18) 18
clinical trials (17) 17
expression (17) 17
rituximab (17) 17
hemic and lymphatic diseases (16) 16
non-hodgkins-lymphoma (16) 16
recurrence (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
drug therapy (15) 15
human necessities (15) 15
hygiene (15) 15
medical or veterinary science (15) 15
preparations for medical, dental, or toilet purposes (15) 15
hematology, oncology and palliative medicine (14) 14
lymphoma, mantle-cell - drug therapy (14) 14
toxicity (14) 14
transplantation (14) 14
adolescent (13) 13
cytarabine - administration & dosage (13) 13
hodgkin lymphoma (13) 13
medical research (13) 13
neoplasm staging (13) 13
specific therapeutic activity of chemical compounds ormedicinal preparations (13) 13
survival analysis (13) 13
tumors (13) 13
abridged index medicus (12) 12
risk factors (12) 12
antineoplastic agents - adverse effects (11) 11
disease-free survival (11) 11
drug administration schedule (11) 11
immunotherapy (11) 11
lymphoma, non-hodgkin - drug therapy (11) 11
radiotherapy (11) 11
analysis (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
apoptosis (10) 10
bortezomib (10) 10
lymphoma, mantle-cell - therapy (10) 10
medicine & public health (10) 10
non-hodgkin-lymphoma (10) 10
pharmacology & pharmacy (10) 10
retrospective studies (10) 10
cell line, tumor (9) 9
combined modality therapy (9) 9
hodgkin disease - drug therapy (9) 9
hodgkin's disease (9) 9
immunochemotherapy (9) 9
leukemia (9) 9
lymphoma, mantle-cell - genetics (9) 9
medicine, experimental (9) 9
progression-free survival (9) 9
prospective studies (9) 9
remission induction (9) 9
trial (9) 9
animals (8) 8
antineoplastic agents (8) 8
antineoplastic agents - pharmacology (8) 8
cyclophosphamide - administration & dosage (8) 8
dose-response relationship, drug (8) 8
gene expression (8) 8
lymphoma, mantle-cell - pathology (8) 8
neoplasms - drug therapy (8) 8
patient outcomes (8) 8
proportional hazards models (8) 8
research (8) 8
response criteria (8) 8
survival rate (8) 8
usage (8) 8
b-cell lymphoma (7) 7
chronic lymphocytic-leukemia (7) 7
cyclophosphamide (7) 7
cyclophosphamide - therapeutic use (7) 7
disease (7) 7
disease progression (7) 7
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (304) 304
French (16) 16
Chinese (2) 2
German (2) 2
Korean (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | ACUTE-LYMPHOBLASTIC-LEUKEMIA | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | PEDIATRIC-ONCOLOGY-SOCIETY | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials | Life Sciences
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. 649 - 659
Activating enhancer of zeste homolog 2 (EZH2) mutations or aberrations of the switch/sucrose non-fermentable (SWI/SNF) complex (eg, mutations or deletions of... 
OVARY | ACTIVATION | METHYLTRANSFERASE | ONCOLOGY | COMPLEXES | EPITHELIOID SARCOMA | HYPERCALCEMIC TYPE | SMARCA4 MUTATIONS | CARCINOMA | CANCER | MALIGNANT RHABDOID TUMORS | Methylation | Lymphomas | Life Sciences | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1250 - 1260
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2001, Volume 19, Issue 3, pp. 742 - 749
Purpose: To assess the feasibility and efficacy of intensive chemotherapy with hematopoietic stem-cell rescue (IC + HCR) in patients with refractory or... 
THERAPY | BONE-MARROW TRANSPLANTATION | ONCOLOGY | MODALITY | METHOTREXATE | PROTOCOL | MALIGNANCIES | HIGH-DOSE CHEMOTHERAPY | RADIOTHERAPY | RADIATION | NERVOUS-SYSTEM LYMPHOMA | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Thiotepa - administration & dosage | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Eye Neoplasms - therapy | Lymphoma, Large-Cell, Immunoblastic - therapy | Busulfan - administration & dosage | Feasibility Studies | Dose-Response Relationship, Drug | Eye Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Lymphoma, Large B-Cell, Diffuse - drug therapy | Neoplasm Recurrence, Local - therapy | Central Nervous System Neoplasms - therapy | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Disease-Free Survival | Lymphoma, T-Cell - drug therapy | Lymphoma, Non-Hodgkin - therapy | Lymphoma, T-Cell - therapy | Lymphoma, Large-Cell, Immunoblastic - drug therapy | Methotrexate - administration & dosage | Nervous System Diseases - chemically induced | Central Nervous System Neoplasms - drug therapy
Journal Article
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2018, Volume 24, Issue 13, pp. 2993 - 2998
The 14th ICML held in Lugano in June 2017 was preceded by a closed workshop (organized in collaboration with the American Association for Cancer Research and... 
CIRCULATING TUMOR DNA | ONCOLOGY | CELL LYMPHOMA | R-CHOP | RESPONSE EVALUATION CRITERIA | TARGETED AGENTS | NON-HODGKIN-LYMPHOMA | BRENTUXIMAB VEDOTIN SGN-35 | FOLLICULAR LYMPHOMA | OPEN-LABEL | PHASE-I | Medical research | Conferences | Clinical trials | Lymphomas | Drug development | Lymphoma | Cancer | Life Sciences
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 3, pp. 267 - 270
Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 1, pp. 48 - 53
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2018, Volume 24, Issue 13, pp. 2993 - 2998
Journal Article